Company: FOACW
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001193125-25-065614
Chunk: 28

Company: Finance of America Companies Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 28
---
 and his leadership on the strategic direction of the Company generally. Key factors that the compensation committee considered in making such determination with respect to Ms. Sieffert were her leadership in the Company’s development and enhancement of its unified modern retirement solutions platform. Key factors the compensation committee considered in making such determination with respect to Mr. Prahm were his role in overseeing and managing the strategic direction of the Company’s Portfolio Management segment. 21

Long-Term Equity Incentives The Company maintains the Finance of America Companies Inc. 2021 Omnibus Incentive Plan (the “Omnibus Plan”) to provide employees and directors of FOA with additional incentives to promote the long-term growth and performance of the Company and to further align the interests of our directors and management with the interests of our stockholders by increasing their ownership interests in the common stock of the Company. The Omnibus Plan is administered by the compensation committee. In 2024, as a long-term incentive, Mr. Fleming, Ms. Sieffert and Mr. Prahm each received a restricted stock unit (“RSU”) grant of 200,000, 125,000 and 200,000 units, respectively (accounting for adjustments for the Company’s 10:1 reverse stock split effective on July 25, 2024). Such RSUs vest ratably over a prospective three-yearperiod, subject to the grantee’s continued employment on the vesting date. See “Summary Compensation Table — Stock Awards” for the grant date fair value of each named executive officer’s RSU award. Options On November 7, 2024, Mr. Fleming, Ms. Sieffert and Mr. Prahm each received a grant of 200,000, 150,000 and 200,000 options to purchase FOA Units exchangeable for shares of Class A Common Stock, respectively (“Options”). The Options vest on November 7, 2026, the second anniversary from the date of grant (subject to the named executive officer’s continued employment on the vesting date), are exercisable for a period ending on November 7, 2029, five years from the date of grant, and have an exercise price of $25.00 per Option. We do not have a formal policy regarding the timing of awards of options in relation to the disclosure of material nonpublic information. The Board does not grant option awards as part of its annual grant of long-term incentiveawards or on any predetermined schedule. Instead, the Board may